logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
Р

Роберто Пили

Roswell Park Comprehensive Cancer Center

74H指数
698论文数
1.9W被引数
收录论文 159
发表时间
logo
Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness住院癌症患者接受阿片类药物管理以治疗化疗诱导的溃疡性黏膜炎，可减轻患者的总体疾病负担。
errPHARMACEUTICALS
IF4.8
err2025-04-06
err0
errOAAI
errMohan, Minu Ponnamma; Epstein, Joel B.; Meleveedu, Kapil S.; Padhi, Parikshit; Pili, Roberto; Satheeshkumar, Poolakkad S.
err分享
err收藏
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer晚期肺癌和前列腺癌的感知疾病严重程度和终末的相关性
errJOURNAL OF PAIN AND SYMPTOM MANAGEMENT
IF3.5
err2025-04-01
err0
PREAI
errDi Palmo, Michaela; Secinti, Ekin; Krueger, Ellen; Hanna, Nasser H.; Adra, Nabil; Durm, Gregory A.; Einhorn, Lawrence; Pili, Roberto; Jalal, Shadia I.; Mosher, Catherine E.
err分享
err收藏
Predictors for Emergency Admission Among Homeless Metastatic Cancer Patients and Association of Social Determinants of Health with Negative Health Outcomes无家可归的转移性癌症患者急诊入院预测因素及社会决定因素与健康不良结局的关联
errCANCERS
IF4.4
err2025-03-27
err0
errOAAI
errSatheeshkumar, Poolakkad S.; Sonis, Stephen T.; Epstein, Joel B.; Pili, Roberto
err分享
err收藏
Receiving immunotherapy for the treatment of advanced renal cell carcinoma is associated with higher burden of illness, coagulopathy, cardiac arrhythmia, and disparities接受免疫疗法治疗晚期肾细胞癌与更高的疾病负担、凝血功能障碍、心律失常以及不平等现象相关。
errSUPPORTIVE CARE IN CANCER
IF3
err2025-03-15
err0
PREAI
errEichhorn, Susan; Pili, Roberto; Epstein, Joel B.; Rajesh, Richa; Satheeshkumar, Poolakkad S.
err分享
err收藏
Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects口服masofaniten（EPI-7386）联合enzalutamide（Enz）与单独使用enzalutamide（Enz）治疗转移性去势抵抗性前列腺癌（mCRPC）受试者的I/II期临床试验
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errKyriakopoulos, C.; Chatta, G.; Laccetti, A. L.; Iannotti, N.; Sokolova, A. O.; Hotte, S. J.; Tutrone, R.; Markowski, M. C.; Nordquist, L. T.; Pili, R.; Saad, F.; Zhang, J.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A.
err分享
err收藏
The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errJawadwala, Abbas; Rupert, Christopher; Adelaiye-Ogala, Remi; Pili, Roberto; Chintala, Sreenivasulu; Orillion, Ashley; Elbanna, May; Damayanti, Nur; Delle Fontane, Ilaria
err分享
err收藏
Metabolic rewiring induced by protein or calorie restriction provides unique therapeutic vulnerabilities in translocation and select clear cell renal cell carcinomas
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errOrsi, Sabrina A.; Rupert, Christopher; Colligan, Sean; Chang, Musea; Jawadwala, Abbas; Delle Fontane, Ilaria; de Nigris, Filomena; Pili, Roberto
err分享
err收藏
The antihistamine terfenadine inhibits TFE3 dimerization, has antitumor activity and synergizes with tyrosine kinase inhibitors in translocation renal cell carcinoma
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errDelle Fontane, Ilaria; Cordova, Ricardo; Rupert, Christopher; Orsi, Sabrina; Jawadwala, Abbas; Heppener, David E.; Pili, Roberto
err分享
err收藏
Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err1
PREAI
errLaccetti, A. L.; Chatta, G.; Kyriakopoulos, C.; Iannotti, N.; Hotte, S. J.; Markowski, M. C.; Pili, R.; Vuky, J.; Zhang, J.; Saad, F.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A.
err分享
err收藏
A mechanistic study of the TFE3-splicing machinery gene fusions reveals a new druggable target for translocation renal cell carcinoma
errCANCER RESEARCH
IF16.6
err2023-08-15
err0
PREAI
errDelle Fontane, Ilaria; Damayanti, Nuri; Rupert, Christopher; Heppner, David E.; Pili, Roberto
err分享
err收藏
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma
errCANCER RESEARCH
IF16.6
err2023-08-15
err0
PREAI
errOrsi, Sabrina; Rupert, Christopher; Pili, Roberto; De Nigris, Filomena
err分享
err收藏
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
errJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
err2023-05-26
err8
errOAAI
errRupert, Christofer; Aversana, Carmela Dell'; Mosca, Laura; Montanaro, Vittorino; Arcaniolo, Davide; De Sio, Marco; Bilancio, Antonio; Altucci, Lucia; Palinski, Wulf; Pili, Roberto; de Nigris, Filomena
err分享
err收藏
Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation
errMOLECULAR & CELLULAR PROTEOMICS
IF5.5
err2023-05-01
err9
errOAAI
errHadisurya, Marco; Lee, Zheng-Chi; Luo, Zhuojun; Zhang, Guiyuan; Ding, Yajie; Zhang, Hao; Iliuk, Anton B.; Pili, Roberto; Boris, Ronald S.; Tao, W. Andy
err分享
err收藏
GCN2 eIF2 kinase and p53 coordinate amino acid homeostasis and metabolism in prostate cancer
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errCordova, Ricardo A.; Sommers, Noah R.; Klunk, Angela J.; Mohiuddin, Haroon M.; Pili, Roberto; Wek, Ronald C.; Staschke, Kirk A.
err分享
err收藏
A mechanistic study of the TFE3-splicing machinery gene fusions reveals a new druggable target for translocation renal cell carcinoma
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errDamayanti, Nur; Orsi, Sabrina; Cordova, Ricardo; Rupert, Christopher; Shen, Li; Linehan, William Marston; Staschke, Kirk; Hollenhorst, Peter; Heppner, David; Pili, Roberto
err分享
err收藏
EZH2 mediated kinome reprogramming drives AR phosphorylation and activation in receptor tyrosine kinase inhibitors resistant renal carcinoma models
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errRupert, Christopher; Metcalf, Stephanie; Rajendran, Saranya; Colligan, Sean; Hollenhorst, Peter; Pili, Roberto
err分享
err收藏
Alternate-day fasting enhances the activity of anti-androgen therapy in prostate cancer models
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errCordova, Ricardo; Elbanna, May; Klunk, Angela; Rupert, Christopher; Shen, Li; Wang, Yanqing; Goodrich, David; Wek, Ron; Staschke, Kirk; Fontana, Luigi; Pili, Roberto
err分享
err收藏
Therapeutic targeting of P2 x 4 receptor and mitochondrial membrane potential in renal cell carcinoma
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errRupert, Christopher; Pili, Roberto; DeNigris, Filomena
err分享
err收藏
Developing HDAC inhibitors as immunomodulators
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errColligan, Sean; Shen, Li; Rupert, Christopher; Bard, Jonathan; Pili, Roberto
err分享
err收藏
Tumor PD-L1 induction associated with dietary protein restriction is modulated by PERK activation
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errCordova, Ricardo; Colligan, Sean; Rupert, Chris; Wek, Ronald; Staschke, Kirk; Pili, Roberto
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
R
Rakesh K. Jain
H 指数: 200 · 论文数: 1.7K
P
Peter Carmeliet
H 指数: 192 · 论文数: 1.4K
A
Adrian L. Harris
H 指数: 187 · 论文数: 2.1K
K
Kari Alitalo
H 指数: 187 · 论文数: 1.1K
G
Gregg L. Semenza
H 指数: 185 · 论文数: 682
查看更多